Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- QLT Announces Fourth Quarter and Year End 2008 Results
- Provides Guidance for 2009 VANCOUVER, Feb. 19 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today reported its financial results for the fourth quarter ending December 31, 2008 and full year 2008 as well as issued its guidance for 2009. Unless specified otherwise, all...
- Research articles 2009-02-19
- QLT announces that it is named as a defendant in an action
- Complaint filed in Superior Court for the Commonwealth of Massachusetts VANCOUVER, Feb. 12 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) announced that on February 11, 2009, the General Hospital Corporation, doing business as Massachusetts General Hospital ("MGH"), filed a complaint in the Superior Court of the Commonwealth...
- Research articles 2009-02-13
- QLT announces final results of tender offer
- VANCOUVER, Jan. 30 /PRNewswire-FirstCall/ -- QLT Inc. ("QLT") (NASDAQ: QLTI; TSX: QLT) announced the final results of its modified "Dutch Auction" tender offer (the "Offer"), which expired at 5:00 p.m. Eastern time on January 26, 2009. QLT has accepted for purchase and cancellation 20,000,000 of its common shares...
- Research articles 2009-01-30
- QLT announces preliminary results of tender offer
- VANCOUVER, Jan. 27 /PRNewswire-FirstCall/ -- QLT Inc. ("QLT") (NASDAQ: QLTI; TSX: QLT) announced the preliminary results of its modified "Dutch Auction" tender offer (the "Offer"), which expired at 5:00 p.m. Eastern time on January 26, 2009. Based on the preliminary report of the depository for the Offer, QLT...
- Research articles 2009-01-27
- QLT to divest Aczone
- Vancouver, B.C.-based QLT Inc. said in mid-March that it would divest its acne therapy Aczone. The company made the announcement in the wake of the Food and Drug Administration's decision to remove a requirement for glucose-6-phosphate dehydrogenase screening and blood monitoring for users. The FDA decision was based on results...
- Research articles 2008-05-01
- QLT announces positive FDA action on Aczone.
- M2 PRESSWIRE-18 March 2008-InvestorInstantMessaging: QLT announces positive FDA action on AczoneC1994-2008 M2 COMMUNICATIONS LTD RDATE:18032008 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world can communicate. Do you have a ...
- Research articles 2008-03-18
- Adds QLT Inc.to our Bluechips Portfolio.
- M2 PRESSWIRE-17 March 2008-Stock Target Upgrade: Adds QLT Inc.to our Bluechips PortfolioC1994-2008 M2 COMMUNICATIONS LTD RDATE:17032008 International Stock Targets is a world renowned independent research firm, based in Johannesburg, South Africa. Along with walking investors through the whole life-cycle of many...
- Research articles 2008-03-17
- Introduces QLT to our Toronto Exchange Watch List.
- M2 PRESSWIRE-23 January 2008-International Stock Targets: Introduces QLT to our Toronto Exchange Watch ListC1994-2008 M2 COMMUNICATIONS LTD RDATE:23012008 International Stock Targets provides investors with the opportunity to cultivate the so-often- taken-for-granted knowledge of the markets and its many drivers. We...
- Research articles 2008-01-23
- Phase 1 of QLT Strategic Restructuring.
- M2 PRESSWIRE-22 January 2008-bellwetherreport.com: Phase 1 of QLT Strategic RestructuringC1994-2008 M2 COMMUNICATIONS LTD RDATE:22012008 Today Bellwether Report has identified QLT Inc. (TSX:QLT) (NASDAQ:QLTI), a company that our analysts will be tracking over the ensuing weeks. They recently came out with a...
- Research articles 2008-01-22
- QLT exploring asset sale to boost shareholder value
- QLT Inc - once one of Canada's most highly valued technology companies - has established a special committee to explore options for selling some or all of its assets. The move follows declining sales of its lead products for age-related macular degeneration and prostate cancer combined with delays in bringing...
- Research articles 2007-12-10
- QLT Inc. Receives Progressive Review.
- M2 PRESSWIRE-14 February 2007-www.streetinvesting.com: QLT Inc. Receives Progressive ReviewC1994-2007 M2 COMMUNICATIONS LTD RDATE:14022007 Please visit www.Streetinvesting.com for the full report. American markets saw phenomenal success Tuesday, as the Dow surged over 100 points on favorable takeover news and an...
- Research articles 2007-02-14
- Fundamental Review for QLT Inc.
- M2 PRESSWIRE-13 February 2007-Biotech News: Fundamental Review for QLT Inc.C1994-2007 M2 COMMUNICATIONS LTD RDATE:13022007 QLT's drugs respond to a light touch. The company develops pharmaceuticals that are activated when exposed to light. Visudyne, developed and marketed with Novartis Ophthalmics, fights a...
- Research articles 2007-02-13
- QLT Inc's Subsidiary QLT USA Inc. On the Move.
- M2 PRESSWIRE-6 December 2006-Pinnacle Digest: QLT Inc's Subsidiary QLT USA Inc. On the MoveC1994-2006 M2 COMMUNICATIONS LTD RDATE:06122006 QLT Inc. (TSX;QLT) (NASDAQ:QLTI) experienced a slight decline in share price Tuesday dipping 1.08, coupled with 64,787 shares trading hands. PinnacleDigest has focused...
- Research articles 2006-12-06
- QLT Stands for Quality!
- M2 PRESSWIRE-31 October 2006-TSX News: QLT Stands for Quality!C1994-2006 M2 COMMUNICATIONS LTD RDATE:31102006 QLT Inc. is a global biopharmaceutical company specializing in developing treatments for eye diseases as well as dermatological and urological conditions. Together with their subsidiaries, they have ...
- Research articles 2006-10-31
- Bellwether Report.com Acknowledges QLT Inc.
- M2 PRESSWIRE-19 October 2006-bellwetherreport.com: Bellwether Report.com Acknowledges QLT IncC1994-2006 M2 COMMUNICATIONS LTD RDATE:19102006 The Bellwether Report Takes Notice of QLT Inc (Nasdaq:QLTI) QLT's drugs respond to a light touch. The company develops pharmaceuticals that are activated when exposed to...
- Research articles 2006-10-19
- Bellwether Report.com Announces an Alert for QLT Inc.
- M2 PRESSWIRE-29 August 2006-bellwetherreport.com: Bellwether Report.com Announces an Alert for QLT Inc.C1994-2006 M2 COMMUNICATIONS LTD RDATE:29082006 The Bellwether Report Takes Notice of QLT Inc. (Nasdaq;QLTI) QLT's drugs respond to a light touch. The company develops pharmaceuticals that are...
- Research articles 2006-08-29
- BDSI Announces Purchase of Non-U.S. BEMA™ Technology from QLT USA, Inc.; Transaction Eliminates Non-U.S. License and Future Milestone and Royalty Obligations To QLT And Provides Option for Purchase Of U.S. Asset
- MORRISVILLE, N.C. -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a specialty biopharmaceutical company focused on acute care products, including pain therapies has purchased from QLT USA, Inc. ("QLT USA"), a subsidiary of QLT Inc. (NASDAQ:QLTI; TSX:QLT) all of the non-U.S. rights to the BEMATM drug delivery technology, including all patent rights...
- Research articles 2006-08-03
- Bellwether Report.com is Tracking QLT Inc.
- M2 PRESSWIRE-27 July 2006-bellwetherreport.com: Bellwether Report.com is Tracking QLT Inc.C1994-2006 M2 COMMUNICATIONS LTD RDATE:27072006 The Bellwether Report Takes Notice of QLT Inc. (Nasdaq:QLTI) QLT's drugs respond to a light touch. The company develops pharmaceuticals that are activated when exposed to light....
- Research articles 2006-07-27
- QLT Inc.(Industry)(Robert Butchofsky )(Brief article)
- Vancouver-based QLT Inc. has appointed Robert Butchofsky as the company's president and CEO, after Butchofsky's successful stint as acting CEO. He was also named a director.
- Research articles 2006-06-01
- The Bellwether Report continues to track QLT Inc.
- M2 PRESSWIRE-26 September 2005-bellwetherreport.com: The Bellwether Report continues to track QLT IncC1994-2005 M2 COMMUNICATIONS LTD RDATE:26092005 Today the Bellwether Report has identified QLT Inc (NASDAQ:QLTI),a company that our analysts will be tracking over the ensuing weeks. They recently came out with...
- Research articles 2005-09-26
- << Previous
- page 1 of 4
- Next >>
